Treating the right patient at the right time: Access to cardiovascular nuclear imaging

Canadian Journal of Cardiology

Volumn 22, Issue 10, 2006, Pages 827-833

  Gulenchyn, K Y ^a,g,h   McEwan, A J ^b,g   Freeman, M ^c,h   Kiess, M ^d,h   O'Neill, B J ^e,h   Beanlands, R S ^f,g,h  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^g Canadian Association of Nuclear Medicine Section   (Canada)

^h Canadian Cardiovascular Society   (Canada)

Author keywords

Myocardial perfusion; Myocardial viability; Positron emission tomography; Radionuclide imaging; SPECT; Ventricular function

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THALLIUM 201; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONSULTATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; SCINTIANGIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; EPIDEMIOLOGY; HEALTH CARE DELIVERY; HEART MUSCLE; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; METHODOLOGY; PATHOLOGY; PATIENT SELECTION; SCINTISCANNING; TIME;

CANADA; CARDIOVASCULAR DISEASES; FLUORODEOXYGLUCOSE F18; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MYOCARDIAL REPERFUSION; MYOCARDIUM; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE ANGIOGRAPHY; RADIOPHARMACEUTICALS; RESEARCH DESIGN; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; WAITING LISTS;

EID: 33749047647     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(06)70300-2     Document Type: Article

References (24)

1. Wait Time Alliance for Timely Access to Health Care. It's about time! Achieving benchmarks and best practices in wait time management. Final report by the Wait Time Alliance for Timely Access to Health Care. (Version current at July 11, 2006).
2. Canadian Society of Nuclear Medicine. Photon. (Version current at July 17, 2006).
3. Patient Access to Care: Cardiac Cathererization, March 31, 2006. Cardiac Care Network of Ontario. (Version current at July 11, 2006).
4. Government of British Columbia Ministry of Health. Surgical wait times. (Version current at July 11, 2006).
5. Alberra Government. Alberta Waitlist Registry. (Version current at July 11, 2006).
6. Manitoba Health. Manitoba wait time information. (Version current at July 10, 2006).
7. Saskatchewan Surgical Care Network. Wait time information. (Version current at July 11, 2006).
8. Cardiac Care Network of Ontario. (Version current at July 11, 2006).
9. Levels of evidence and grades of recommendations: A comparison of guideline developer's evidence taxonomies. (Version current at July 11, 2006).
10. American College of Radiology. ACR Appropriatenesss Criteria. (Version current at July 11, 2006).
11. CC/AHA/ASNC Guidelines for the clinical use of cardiac radionuclide imaging. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (Version current at July 11, 2006).
12. Tanser P. 2000 revision of the Canadian Cardiovascular Society 1997 Consensus Conference on the Evaluation and Management of Chronic Ishemic Heart Disease. Can J Cardiol 2000;16:1513-36.
13. Mowatt G, Vale L, Brazzelli M, et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Health Technol Assess 2004;8:1-270.
14. O'Neill BJ, Brophy JM, Simpson CS, et al; Canadian Cardiovascular Society Access to Care Working Group. General commentary on access to cardiovascular care in Canada: Universal access, but when? Treating the right patient at the right time. Can J Cardiol 2005;21:1272-6.
15. Graham MM, Knudtson ML, O'Neill BJ, Ross DB. Treating the right patient at the right time: Access to cardiac catheterization, percutaneous coronary intervention and cardiac surgery. Can J Cardiol 2006;22:679-83.
16. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:141-86.
17. Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 1998;98(19 Suppl):II51-6.
18. Canadian Institute for Health Information. Medical Imaging in Canada 2004. (Version current at July 11, 2006).
19. Medical Services Advisory Committee. Positron emission tomography. (Version current at July 17, 2006).
20. Adams E, Asua J, Olasagasti JC, Erlichman M, Flynn K, Hurtado-Saracho I. Positron emission tomography: Experience with PET and synthesis of the evidence. (Version current at July 11, 2006).
21. Robert G, Milne R. Positron emission tomography: Establishing priorities for health technology assessment. (Version current at July 11, 2006).
22. Laupacis A, Paszat L, Hodgson D, Benk V. Health technology assessment of positron emission tomography (PET) - A systematic review. ICES Investigative Report. (Version current at July 11, 2006).
23. Adams E, Flynn K. Positron emission tomography. Descriptive analysis of experience with PET in VA: A Systematic review update of FDG-PET as a diagnostic test in cancer and Alzheimer's disease. (Version current at July 11, 2006).
24. Dussault FP, Nguyen VH, Rachet F. Positron emission tomography in Québec. (Version current at July 11, 2006).